Pentoxifylline as an adjunct therapy in children with cerebral malaria

BACKGROUND: Pentoxifylline (PTX) affects many processes that may contribute to the pathogenesis of severe malaria and it has been shown to reduce the duration of coma in children with cerebral malaria. This pilot study was performed to assess pharmacokinetics, safety and efficacy of PTX in African c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lell, Bertrand, Köhler, Carsten, Wamola, Betty, Olola, Christopher HO, Kivaya, Esther, Kokwaro, Gilbert, Wypij, David, Mithwani, Sadik, Taylor, Terrie E, Kremsner, Peter G, Newton, Charles RJC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152769/
https://www.ncbi.nlm.nih.gov/pubmed/21176151
http://dx.doi.org/10.1186/1475-2875-9-368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152769/
https://www.ncbi.nlm.nih.gov/pubmed/21176151
http://dx.doi.org/10.1186/1475-2875-9-368

Ejemplares similares